Implantable Devices Are Not A Panacea, But The Ability To Relieve Migraine Attacks

Implantable Devices Are Not A Panacea, But The Ability To Relieve Migraine Attacks.


An implantable slogan recondite in the nape of the neck may want more headache-free days for people with severe migraines that don't respond to other treatments, a young study suggests. More than 36 million Americans get migraine headaches, which are marked by powerful pain, sensitivity to light and sound, nausea and vomiting, according to the Migraine Research Foundation peyronies. Medication and lifestyle changes are the first-line treatments for migraine, but not all improves with these measures.



The St Jude Medical Genesis neurostimulator is a short, poor strip that is implanted behind the neck. A battery package is then implanted elsewhere in the body. Activating the device stimulates the occipital nerve and can cloudy the pain of migraine headache peins largement with sarson ka oil. "There are a large number of patients for whom nothing works and whose lives are ruined by the day after day pain of their migraine headache, and this device has the potential to help some of them," said ruminate on author Dr Stephen D Silberstein, director of the Jefferson Headache Center in Philadelphia.



The study, which was funded by coat of arms manufacturer St Jude Medical Inc, is slated for giving on Thursday at the International Headache Congress in Berlin, and is the largest study to date on the device. The attendance is now seeking approval for the device in Europe and then plans to submit their data to the US Food and Drug Administration for rubber stamp in the United States.



Researchers tested the new device in 157 community who had severe migraines about 26 days out of each month. After 12 weeks, those who received the recent device had seven more headache-free days per month, compared to one more headache-free day per month seen all people in the control group.



Individuals in the control arm did not receive stimulation until after the start with 12 weeks. Study participants who received the stimulator also reported less severe headaches and improvements in their eminence of life. After one year, 66 percent of people in the study said they had matchless or good pain relief.



The pain reduction seen in the study did fall short of FDA standards, which collect for a 50 percent reduction in pain. "The device is invisible to the eye, but not to the touch". The implantation way involves local anesthesia along with conscious sedation so you are awake, but not fully aware.



There may be some lenient pain associated with this surgery. Study co-author Dr Joel Saper, sink and director of Michigan Head Pain and Neurological Institute in Ann Arbor, and a colleague of the advisory board for the Migraine Research Foundation, said this therapy could be an important option for some commoners with migraines.



And "There were numerous patients who did benefit in terms of pain control and quality of life. We don't have any without exception effective therapies for migraine, so we don't ever expect everyone to have expressive results, but for those few that it works in, it's life-changing".



But "it is surgical and there are risks to surgery, and there are unknowns such as how large the effects will last". Risks of the new neurostimulation procedure may include infection and the symbol can sometimes dislodge.



Saper has not received any compensation from the device manufacturer. "Occipital nerve stimulation is a healing of great promise for patients with intractable chronic migraine," said Dr Richard B Lipton, chief honcho of the Headache Center at Albert Einstein College of Medicine/Montefiore Medical Center in the Bronx and a council member of the Migraine Research Foundation.



He is not affiliated with the new study. "Eliminating a directly week per month of headaches is a huge gain for chronic migraine sufferers and translates into big improvements in remedying satisfaction and quality of life. This treatment will make a huge incongruity for millions of migraine sufferers with chronic migraine".



The results do mirror what Lipton has seen in his practice. "This shows that the curing can give chronic migraine sufferers their lives back".



Dr Robert Duarte, principal of the Pain Center at North Shore-Long Island Jewish Health System in Manhasset, NY, said that the fresh device should not be considered a first-line treatment for migraine, however. "You necessity to be evaluated by a headache specialist, and make sure all treatment options are tried before installing a stimulator, but it is an selection and there is definitely evidence that it works".



Duarte is not affiliated with the new study. "It is not a cure, but a therapy option that can reduce frequency and intensity of headaches in some people" malish. Doctors can also do a trial run using an outside stimulator to see if it will work before implanting the device.

tag : migraine device study headache chronic headaches center month people

Post a comment

Private comment

Профиль

alejandrafalto

Author:alejandrafalto
Dr. Alejandra Falto

Новые записи
Новые комментарии
Новые трэкбэки
Архив по месяцам
Категории
Форма поиска
RSS ссылка
Ссылки
Формуляр приглашения в блог-друзья

Добавить автора в блог-друзья